Monopar Therapeutics Inc. (MNPR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 483.94M |
| Enterprise Value | 422.26M |
| P/E Ratio | -46.03 |
| PEG Ratio | 1.61 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 7.03 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -36.16 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.13 |
| Return On Equity | -0.13 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -13.72M |
| Net Income | -13.72M |
| Diluted EPS | -1.85 |
Balance Sheet
| Total Cash | 134.3M |
| Total Cash/Share | 15.72 |
| Total Debt | 107,829 |
| Total Debt/Equity | 0 |
| Current Ratio | 33.56 |
| Book Value Per Share | 15.32 |
Price History
| 52-Week Change | 236 |
| 52-Week High | 124.82 |
| 52-Week Low | 29.18 |
| Moving Average 50 Days | 99.77 |
| Moving Average 200 Days | 73.37 |
Statistics
| Average Volume | 216,137 |
| Shares Outstanding | 6.7M |
| % Held by Institutions | 93.18 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
| Last Split Date | August 13, 2024 |
AD
